Brokerages predict that Procter & Gamble Company (The) (NYSE:PG) will post $17.32 billion in sales for the current quarter, according to Zacks. Eight analysts have provided estimates for Procter & Gamble’s earnings. The lowest sales estimate is $17.12 billion and the highest is $17.59 billion. Procter & Gamble reported sales of $16.86 billion during the same quarter last year, which would suggest a positive year over year growth rate of 2.7%. The business is expected to issue its next earnings report before the market opens on Friday, January 19th.

On average, analysts expect that Procter & Gamble will report full year sales of $17.32 billion for the current year, with estimates ranging from $66.58 billion to $67.53 billion. For the next fiscal year, analysts anticipate that the company will post sales of $68.79 billion per share, with estimates ranging from $68.32 billion to $69.47 billion. Zacks’ sales averages are a mean average based on a survey of research analysts that follow Procter & Gamble.

Procter & Gamble (NYSE:PG) last released its quarterly earnings data on Friday, October 20th. The company reported $1.09 EPS for the quarter, beating the consensus estimate of $1.07 by $0.02. Procter & Gamble had a return on equity of 20.35% and a net margin of 23.72%. The company had revenue of $16.65 billion for the quarter, compared to analysts’ expectations of $16.69 billion. During the same period last year, the firm posted $1.03 earnings per share. Procter & Gamble’s revenue was up .8% compared to the same quarter last year.

Several research firms recently commented on PG. Jefferies Group reissued a “buy” rating and issued a $104.00 target price (up from $103.00) on shares of Procter & Gamble in a research report on Wednesday, September 20th. Deutsche Bank assumed coverage on Procter & Gamble in a research report on Wednesday, December 13th. They issued a “buy” rating and a $101.00 target price on the stock. Zacks Investment Research cut Procter & Gamble from a “buy” rating to a “hold” rating in a research report on Wednesday, October 18th. Goldman Sachs Group reissued a “sell” rating on shares of Procter & Gamble in a research report on Wednesday, October 4th. Finally, Vetr cut Procter & Gamble from a “buy” rating to a “hold” rating and set a $90.38 target price on the stock. in a research report on Tuesday, November 7th. Two research analysts have rated the stock with a sell rating, nine have given a hold rating and nine have assigned a buy rating to the stock. The stock currently has an average rating of “Hold” and an average price target of $88.57.

Shares of Procter & Gamble (PG) opened at $90.54 on Thursday. The company has a current ratio of 0.91, a quick ratio of 0.75 and a debt-to-equity ratio of 0.37. Procter & Gamble has a 12-month low of $83.24 and a 12-month high of $94.67. The company has a market capitalization of $229,700.00, a price-to-earnings ratio of 24.21, a P/E/G ratio of 2.95 and a beta of 0.67.

In other news, insider Carolyn M. Tastad sold 5,300 shares of the firm’s stock in a transaction dated Monday, November 13th. The stock was sold at an average price of $89.18, for a total value of $472,654.00. Following the transaction, the insider now owns 57,191 shares of the company’s stock, valued at $5,100,293.38. The transaction was disclosed in a filing with the Securities & Exchange Commission, which can be accessed through this link. Also, insider Marylynn Fergusonmchugh sold 4,363 shares of the firm’s stock in a transaction dated Tuesday, November 7th. The stock was sold at an average price of $87.00, for a total value of $379,581.00. Following the completion of the transaction, the insider now directly owns 85,495 shares in the company, valued at approximately $7,438,065. The disclosure for this sale can be found here. Insiders sold 21,575 shares of company stock worth $1,927,095 in the last ninety days. Corporate insiders own 0.35% of the company’s stock.

Several hedge funds and other institutional investors have recently bought and sold shares of PG. Truepoint Inc. raised its stake in Procter & Gamble by 8,711.3% during the 3rd quarter. Truepoint Inc. now owns 26,889,686 shares of the company’s stock valued at $26,890,000 after purchasing an additional 26,584,514 shares during the period. Capital Research Global Investors raised its stake in Procter & Gamble by 74.2% during the 2nd quarter. Capital Research Global Investors now owns 12,389,104 shares of the company’s stock valued at $1,079,710,000 after purchasing an additional 5,278,359 shares during the period. Janus Henderson Group PLC raised its stake in Procter & Gamble by 1,244.6% during the 2nd quarter. Janus Henderson Group PLC now owns 4,500,564 shares of the company’s stock valued at $392,226,000 after purchasing an additional 4,165,862 shares during the period. Vanguard Group Inc. raised its stake in Procter & Gamble by 2.3% during the 2nd quarter. Vanguard Group Inc. now owns 180,730,770 shares of the company’s stock valued at $15,750,688,000 after purchasing an additional 4,066,266 shares during the period. Finally, Stifel Financial Corp raised its stake in Procter & Gamble by 60,483.0% during the 3rd quarter. Stifel Financial Corp now owns 2,423,319 shares of the company’s stock valued at $220,392,000 after purchasing an additional 2,419,319 shares during the period. 59.56% of the stock is currently owned by hedge funds and other institutional investors.

TRADEMARK VIOLATION WARNING: This article was first reported by American Banking News and is the sole property of of American Banking News. If you are reading this article on another publication, it was illegally copied and reposted in violation of international copyright and trademark legislation. The original version of this article can be read at https://www.americanbankingnews.com/2018/01/04/17-32-billion-in-sales-expected-for-procter-gamble-company-the-pg-this-quarter.html.

Procter & Gamble Company Profile

The Procter & Gamble Company is focused on providing branded consumer packaged goods to the consumers across the world. The Company operates through five segments: Beauty; Grooming; Health Care; Fabric & Home Care, and Baby, Feminine & Family Care. The Company sells its products in approximately 180 countries and territories primarily through mass merchandisers, grocery stores, membership club stores, drug stores, department stores, distributors, baby stores, specialty beauty stores, e-commerce, high-frequency stores and pharmacies.

Get a free copy of the Zacks research report on Procter & Gamble (PG)

For more information about research offerings from Zacks Investment Research, visit Zacks.com

Earnings History and Estimates for Procter & Gamble (NYSE:PG)

Receive News & Ratings for Procter & Gamble Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Procter & Gamble and related companies with MarketBeat.com's FREE daily email newsletter.